Locanabio pulls in $100m Series B
Locanabio Inc, an RNA-targeting gene therapy company, has raised $100 million in Series B financing.
Locanabio Inc, an RNA-targeting gene therapy company, has raised $100 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination